India
#00285
Implements
#00385 Enforce science-based discharge limits for antibiotic manufacturing
Implementer
India Ministry of Environment, Forest and Climate Change and Central Pollution Control Board
Location
Description
In January 2020, India published draft environmental rules proposing concentration limits for residues of 121 antibiotics in treated effluent from bulk-drug and formulation facilities — a proposal that would have created the first national antibiotic-specific manufacturing discharge limits. After consultation, the final 2021 rules removed the antibiotic-specific limits entirely. The available evidence documents industry objections and the policy outcome but does not establish a single causal explanation for the removal.
Lessons learned
- Publishing a technically ambitious draft does not ensure that limits survive consultation and implementation: the 121-antibiotic proposal reached formal consultation in India but was dropped from the 2021 final rules.
- Antibiotic-specific discharge standards require validated analytical methods, demonstrated regulatory monitoring capacity, and an explicit strategy for managing industry transition costs before consultation — their absence creates vulnerability to industry objections.
- When documenting or replicating this approach, policy histories must distinguish proposed standards from final enforceable rules, as the gap between the two is where implementation fails.
Sources
2